Cargando…

Early Detrusor Application of Botulinum Toxin A Results in Reduced Bladder Hypertrophy and Fibrosis after Spinal Cord Injury in a Rodent Model

Following spinal cord injury (SCI), pathological reflexes develop that result in altered bladder function and sphincter dis-coordination, with accompanying changes in the detrusor. Bladder chemodenervation is known to ablate the pathological reflexes, but the resultant effects on the bladder tissue...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bushnell, Juliana Y., Cates, Lindsay N., Hyde, Jeffrey E., Hofstetter, Christoph P., Yang, Claire C., Khaing, Zin Z.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9697114/ https://www.ncbi.nlm.nih.gov/pubmed/36356027 http://dx.doi.org/10.3390/toxins14110777

Ejemplares similares

Botulinum toxin in spinal cord injury patients with neurogenic detrusor overactivity
por: Cho, Young Sam, et al.
Publicado: (2016)

Will repeated botulinum toxin A improve detrusor overactivity and bladder compliance in patients with chronic spinal cord injury?
por: Chen, Sheng-Fu, et al.
Publicado: (2020)

Botulinum Toxin in Neurogenic Detrusor Overactivity
por: D'Ancona, Carlos Arturo Levi, et al.
Publicado: (2012)

CONCOMITANT DETRUSOR AND EXTERNAL URETHRAL SPHINCTER BOTULINUM TOXIN-A INJECTIONS IN MALE SPINAL CORD INJURY PATIENTS WITH DETRUSOR OVERACTIVITY AND DETRUSOR SPHINCTER DYSSYNERGIA
por: HUANG, Yu-Hui, et al.
Publicado: (2022)

Clinical Efficacy and Changes of Urothelial Dysfunction after Repeated Detrusor Botulinum Toxin A Injections in Chronic Spinal Cord-Injured Bladder
por: Chen, Sheng-Fu, et al.
Publicado: (2016)

Long-term response of different Botulinum toxins in refractory neurogenic detrusor overactivity due to spinal cord injury
por: Lombardi, Giuseppe, et al.
Publicado: (2017)

Role of botulinum toxin-A in management of refractory idiopathic detrusor overactive bladder: Single center experience
por: Mohanty, N. K., et al.
Publicado: (2008)

Clinical outcomes of botulinum toxin A management for neurogenic detrusor overactivity: meta-analysis
por: Wu, Shang-Jun, et al.
Publicado: (2019)

Botulinum Toxin A Injection for Autonomic Dysreflexia—Detrusor Injection or Urethral Sphincter Injection?
por: Chow, Po-Ming, et al.
Publicado: (2023)

Long-term follow-up after botulinum toxin A (BTX-A) injection into the detrusor for treatment of neurogenic detrusor hyperactivity in children
por: Zeino, Mazen, et al.
Publicado: (2012)

The Efficacy and Safety of Intrasphincteric Botulinum Toxin-A Injections in Patients with Non-Spinal Cord Injury-Related Detrusor Sphincter Dyssynergia: A Retrospective Study
por: Röthlin, Kilian, et al.
Publicado: (2023)

AB204. Repeated intradetrusor botulinum toxin type A injections are still effective for patients with neurogenic detrusor overactivity secondary to spinal cord injury in China
por: Chen, Hui, et al.
Publicado: (2016)

Editorial Comment: Solifenacin treatment after intradetrusor injections with botulinum toxin in patients with neurogenic detrusor overactivity
por: Averbeck, Marcio Augusto
Publicado: (2022)

Abobotulinum - a toxin injection in patients with refractory idiopathic detrusor overactivity: injections in detrusor, trigone and bladder neck or prostatic urethra, versus detrusor - only injections
por: Emami, Maryam, et al.
Publicado: (2017)

Functional Polymorphism in the ADRB3 Gene, Encoding the Beta-3 Adrenergic Receptor, and Response to Intra-Detrusor Injection of Botulinum Toxin-A in Women with Overactive Bladder
por: Ciećwież, Sylwester Michał, et al.
Publicado: (2022)

Botulinum toxin A for the Treatment of Overactive Bladder
por: Hsieh, Po-Fan, et al.
Publicado: (2016)

Botulinum Toxin A Injection for Hemihypertrophy-related Unilateral Gastrocnemius Hypertrophy
por: Zhang, Ziming, et al.
Publicado: (2023)

Treatment of at-level spinal cord injury pain with botulinum toxin A
por: Chun, Audrey, et al.
Publicado: (2019)

The Botulinum Treatment of Neurogenic Detrusor Overactivity: The Double-Face of the Neurotoxin
por: Traini, Chiara, et al.
Publicado: (2019)

AMPK Alters Detrusor Contractility During Emptying in Normal Bladder and Hypertrophied Bladder with Partial Bladder Outlet Obstruction via CaMKKβ
por: Choi, Bo-Hwa, et al.
Publicado: (2019)

The use of botulinum toxin for the treatment of overactive bladder syndrome
por: Orasanu, Bogdan, et al.
Publicado: (2013)

The role of botulinum toxin A in treating neurogenic bladder
por: Weckx, Filip, et al.
Publicado: (2016)

Molecular and functional characterization of detrusor PDGFRα positive cells in spinal cord injury-induced detrusor overactivity
por: Lee, Ken, et al.
Publicado: (2021)

AB207. Combined detrusor and external urethral sphincter botulinum toxin A injections is a safe and effective treatment for decreasing leak point pressure in patients with incontinence secondary to spinal cord injury
por: Chen, Hui, et al.
Publicado: (2016)

Lower facial remodeling with botulinum toxin type A for the treatment of masseter hypertrophy
por: Klein, Fernanda Homem de Mello de Souza, et al.
Publicado: (2014)

Ultrasound-guided five-point injection of botulinum toxin for patients with trapezius hypertrophy
por: Chen, Wanying, et al.
Publicado: (2021)

Botulinum toxin type A for neuropathic pain in patients with spinal cord injury
por: Han, Zee‐A, et al.
Publicado: (2016)

Botulinum Toxin: From Poison to Possible Treatment for Spasticity in Spinal Cord Injury
por: Palazón-García, Ramiro, et al.
Publicado: (2021)

Satisfaction with Detrusor OnabotulinumtoxinA Injections and Conversion to Other Bladder Management in Patients with Chronic Spinal Cord Injury
por: Chen, Sheng-Fu, et al.
Publicado: (2022)

Detrusor underactivity: To tone or not to tone the bladder?
por: Krishnamoorthy, Sriram, et al.
Publicado: (2009)

Learning Curve of Botulinum Toxin Bladder Injection for the Treatment of Refractory Overactive Bladder
por: Barba, Marta, et al.
Publicado: (2022)

A Case of Painful Hemimasticatory Spasm with Masseter Muscle Hypertrophy Responsive to Botulinum Toxin
por: Kim, Jin-Hyuck, et al.
Publicado: (2009)

Prevention and correction of paradoxical masseteric bulging following botulinum toxin injection for masseter hypertrophy
por: Rice, Shauna M., et al.
Publicado: (2021)

Antispastic therapy with botulinum toxin type A in patients with traumatic spinal cord lesion
por: Spiegl, Ulrich J., et al.
Publicado: (2014)

Botulinum toxin: An emerging therapy in female bladder outlet obstruction
por: Pradhan, Aditya A.
Publicado: (2009)

Emerging treatments for overactive bladder: clinical potential of botulinum toxins
por: Tincello, Douglas G, et al.
Publicado: (2014)

Botulinum toxin-A for the treatment of overactive bladder: UK contributions
por: Seth, JH, et al.
Publicado: (2013)

Botulinum Toxin A for Bladder Pain Syndrome/Interstitial Cystitis
por: Chiu, Bin, et al.
Publicado: (2016)

Inosine Improves Neurogenic Detrusor Overactivity following Spinal Cord Injury
por: Chung, Yeun Goo, et al.
Publicado: (2015)

Association between detrusor muscle function and level of the spinal cord injury
por: Kooshesh, Maryam, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_vcgueed1ihog4lglou4seqqrlo